These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19923004)

  • 1. Dual role of Zn2+ in maintaining structural integrity and suppressing deacetylase activity of SIRT1.
    Chen L; Feng Y; Zhou Y; Zhu W; Shen X; Chen K; Jiang H; Liu D
    J Inorg Biochem; 2010 Feb; 104(2):180-5. PubMed ID: 19923004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of Sirt1 NAD+-dependent Protein Deacetylase Inhibition by Cysteine S-Nitrosation.
    Kalous KS; Wynia-Smith SL; Olp MD; Smith BC
    J Biol Chem; 2016 Dec; 291(49):25398-25410. PubMed ID: 27756843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fluorometric assay of SIRT1 deacetylation activity through quantification of nicotinamide adenine dinucleotide.
    Feng Y; Wu J; Chen L; Luo C; Shen X; Chen K; Jiang H; Liu D
    Anal Biochem; 2009 Dec; 395(2):205-10. PubMed ID: 19682970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of the cellular deacetylase activity of SIRT1 on p53 via LanthaScreen® technology.
    Robers MB; Loh C; Carlson CB; Yang H; Frey EA; Hermanson SB; Bi K
    Mol Biosyst; 2011 Jan; 7(1):59-66. PubMed ID: 20931131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Greater binding affinity of trivalent antimony to a CCCH zinc finger domain compared to a CCHC domain of kinetoplastid proteins.
    Frézard F; Silva H; Pimenta AM; Farrell N; Demicheli C
    Metallomics; 2012 May; 4(5):433-40. PubMed ID: 22454083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol is not a direct activator of SIRT1 enzyme activity.
    Beher D; Wu J; Cumine S; Kim KW; Lu SC; Atangan L; Wang M
    Chem Biol Drug Des; 2009 Dec; 74(6):619-24. PubMed ID: 19843076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of human SIRT1 activation by resveratrol.
    Borra MT; Smith BC; Denu JM
    J Biol Chem; 2005 Apr; 280(17):17187-95. PubMed ID: 15749705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative deacetylase activity of wild type and mutants of SIRT1.
    Malik R; Kashyap A; Bansal K; Sharma P; Rayasam GV; Davis JA; Bora RS; Ray A; Saini KS
    Biochem Biophys Res Commun; 2010 Jan; 391(1):739-43. PubMed ID: 19944070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol is neuroprotective because it is not a direct activator of Sirt1-A hypothesis.
    Tang BL
    Brain Res Bull; 2010 Mar; 81(4-5):359-61. PubMed ID: 20026255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for allosteric, substrate-dependent stimulation of SIRT1 activity by resveratrol.
    Cao D; Wang M; Qiu X; Liu D; Jiang H; Yang N; Xu RM
    Genes Dev; 2015 Jun; 29(12):1316-25. PubMed ID: 26109052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors.
    Lu Q; Yang YT; Chen CS; Davis M; Byrd JC; Etherton MR; Umar A; Chen CS
    J Med Chem; 2004 Jan; 47(2):467-74. PubMed ID: 14711316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirtuin 1 (SIRT1): the misunderstood HDAC.
    Stünkel W; Campbell RM
    J Biomol Screen; 2011 Dec; 16(10):1153-69. PubMed ID: 22086720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural analysis of the inhibitory effects of polyphenols, (+)-hopeaphenol and (-)-isohopeaphenol, on human SIRT1.
    Loisruangsin A; Hikita K; Seto N; Niwa M; Takaya Y; Kaneda N
    Biofactors; 2019 Mar; 45(2):253-258. PubMed ID: 30537158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT1 regulates Tat-induced HIV-1 transactivation through activating AMP-activated protein kinase.
    Zhang HS; Wu MR
    Virus Res; 2009 Dec; 146(1-2):51-7. PubMed ID: 19720090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structures of Sirt3 complexes with 4'-bromo-resveratrol reveal binding sites and inhibition mechanism.
    Nguyen GT; Gertz M; Steegborn C
    Chem Biol; 2013 Nov; 20(11):1375-85. PubMed ID: 24211137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide switch is essential for Sirt1 deacetylase activity.
    Kang H; Suh JY; Jung YS; Jung JW; Kim MK; Chung JH
    Mol Cell; 2011 Oct; 44(2):203-13. PubMed ID: 22017869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol serves as a protein-substrate interaction stabilizer in human SIRT1 activation.
    Hou X; Rooklin D; Fang H; Zhang Y
    Sci Rep; 2016 Nov; 6():38186. PubMed ID: 27901083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT1, a histone deacetylase, regulates prion protein-induced neuronal cell death.
    Seo JS; Moon MH; Jeong JK; Seol JW; Lee YJ; Park BH; Park SY
    Neurobiol Aging; 2012 Jun; 33(6):1110-20. PubMed ID: 21074897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific effects of zinc on the activity of family II pyrophosphatase.
    Zyryanov AB; Tammenkoski M; Salminen A; Kolomiytseva GY; Fabrichniy IP; Goldman A; Lahti R; Baykov AA
    Biochemistry; 2004 Nov; 43(45):14395-402. PubMed ID: 15533044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells.
    Breitenstein A; Stein S; Holy EW; Camici GG; Lohmann C; Akhmedov A; Spescha R; Elliott PJ; Westphal CH; Matter CM; Lüscher TF; Tanner FC
    Cardiovasc Res; 2011 Feb; 89(2):464-72. PubMed ID: 20978007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.